Literature DB >> 10650845

Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group.

S Ehrenforth1, R Junker, H G Koch, W Kreuz, N Münchow, I Scharrer, U Nowak-Göttl.   

Abstract

UNLABELLED: To evaluate the role of multiple established and potential causes of childhood thrombophilia, 285 children with a history of thrombosis aged neonate to 18 years (first thrombotic onset) were investigated and compared with 185 healthy peers. APC-resistance (FV:Q506), protein C, protein S, antithrombin, heparin cofactor II (HCII), histidine-rich glycoprotein (HRGP), and prothrombin (F.II), factor XII (F.XII), plasminogen, homocysteine and lipoprotein (a) (Lp(a)) were investigated. In 59% of patients investigated one thrombotic defect was diagnosed, 19.6% showed two thrombotic risk factors, while in 21.4% of children investigated no risk factor could be identified. Single defects comprised established causes of inherited thrombophilia: FV:Q506 (homozygous n = 10, heterozygous n = 69), protein C (homozygous n = 1; heterozygous n = 31), heterozygous type I deficiency states of protein S (n = 7), antithrombin (n = 7) and homocystinuria (n = 6); potentially inherited clotting abnormalities which may be associated with thrombophilia: F.XII (n = 3), plasminogen (n = 2), HCII (n = 1), increased HRGP (n = 4); new candidate risk factors for thrombophilia: elevated plasma levels of Lp(a) (n = 26), F.II (n = 1). Heterozygous FV:Q506 was found in combination with heterozygous type I deficiency states of protein C (n = 2), protein S (n = 13), antithrombin (n = 8) and HCII (n = 1), increased Lp(a) (n = 13), and once each with elevated levels of F.II, moderate hyperhomocysteinemia, fibrinogen concentrations > 700 mg/dl and increased HRGP. In addition to the association with FV:Q506, heterozygous protein C type I deficiency was combined with deficiencies of protein S (n = 2), antithrombin (n = 1), and increased Lp(a) (n = 3). One patient showed protein C deficiency along with familially increased von Willebrand factor > 250%. Besides coexistence with FV:Q506 and protein C deficiency, protein S deficiency was combined with decreased F.XII and increased Lp(a) in one subject each. Furthermore, we found combinations of antithrombin deficiency/elevated Lp(a), hyperhomocysteinemia/Lp(a), deficiency of HCII/plasminogen, and plasminogen deficiency along with increased Lp(a) each in one. Increased prothrombin levels were associated with fibrinogen concentrations > 700 mg/dl and with HCII deficiency in one child each. Carrier frequencies of single and combined defects were significantly higher in patients compared with the controls.
CONCLUSION: In conclusion, data of this multicentre evaluation indicate that paediatric thromboembolism should be viewed as a multifactorial disorder.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10650845     DOI: 10.1007/pl00014359

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  8 in total

1.  Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study.

Authors:  Lesley Mitchell; Moritz Lambers; Silke Flege; Gili Kenet; Valerie Li-Thiao-Te; Susanne Holzhauer; Christoph Bidlingmaier; Michael C Frühwald; Christine Heller; Wolfgang Schmidt; Brigitte Pautard; Ulrike Nowak-Göttl
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

2.  Pediatric thromboembolism: a national survey in Japan.

Authors:  Akira Ishiguro; Chibueze Chioma Ezinne; Nobuaki Michihata; Hisaya Nakadate; Atsushi Manabe; Masashi Taki; Midori Shima
Journal:  Int J Hematol       Date:  2016-08-18       Impact factor: 2.490

Review 3.  Thrombosis in children: Which test to whom, when and how much necessary?

Authors:  Tiraje Celkan; Gürcan Dikme
Journal:  Turk Pediatri Ars       Date:  2018-03-01

Review 4.  Rare thrombophilic conditions.

Authors:  Gian Luca Salvagno; Chiara Pavan; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2018-09

5.  Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants.

Authors:  Benjamin J Samelson-Jones; Jonathan D Finn; Leslie J Raffini; Elizabeth P Merricks; Rodney M Camire; Timothy C Nichols; Valder R Arruda
Journal:  Blood Adv       Date:  2021-03-09

6.  Multiple presence of prothrombotic risk factors in Croatian children with arterial ischemic stroke and transient ischemic attack.

Authors:  Jasna Leniček Krleža; Vlasta Ðuranović; Ana Bronić; Desiree Coen Herak; Vlatka Mejaški-Bošnjak; Renata Zadro
Journal:  Croat Med J       Date:  2013-08       Impact factor: 1.351

7.  Effort thrombosis (Paget-Schroetter syndrome) in a 16-year-old male.

Authors:  Taylor R Spencer; Richard E Lagace; George Waterman
Journal:  Am J Case Rep       Date:  2014-08-07

Review 8.  Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease.

Authors:  Eman Abdelghani; Clifford L Cua; Jean Giver; Vilmarie Rodriguez
Journal:  Cardiol Ther       Date:  2021-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.